All your arguments seem valid when taken at face value, but you have owned this company long enough to know that this is not the case.
After living through all of Mir's predecessors, it becomes clear that just having a good story has never been enough. If that were the case, the trials would have been completed years ago and sales would have zoomed.
While Mir can raise money, it appears this has been accomplished by issuing shares and diluting the value for those who have held on.He bragged about getting price from teens to nearly fifty cents upon arrival but never says a word now that is hovers on either side of twenty cents.
As to the JD-MD, maybe she has a guaranteed contract that pays her out of the sales of shares and she has no long-term goal to stay on. People no longer have any loyalty to their employers and you should not assume she is in it for anything more than experience and resume padding at a decent, even if short-term salary.
As to trials and needed efficacy, recall that we were told on numerous occasions that trials were underway, that trisl were completed, etc. and that approvals were soon to occur. Then we heard that the codes, etc were rejected for various reasons, and so on..... Needless to say, we seem to be back to where we were when Nano was around with little to show for the time but a lower share price, a well-compensated CEO who remains mum as much as possible, numerous lawsuits hanging over the company, and, form ost shareholders a great opportunity for tax losses.
